14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Oct 21, 2026
BACQ vs ATII: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Oct 21, 2026, Archimedes Tech Spac Partners Ii Co. (ATII) is the stronger overall head-to-head candidate over Bleichroeder Acquisition Corp. I Class A (BACQ) in the Tradestie Institutional Equity Comparison Engine, winning 1–3 core matrix metrics and 1–1 across our 6-pillar institutional scorecard (led by Balance Sheet & Cash Flow). BACQ carries a Unified Composite Score of 48.0/100 (HOLD) at $7.68 (N/M Forward P/E, 0.0% operating margin), whereas ATII carries 41.9/100 (SELL) at $9.81 (N/M Forward P/E, 0.0% operating margin).
Composite vs. Pillar Nuance: While BACQ currently prints a higher short-term Unified Composite Score (48.0/100 HOLD vs. ATII 41.9/100 SELL), ATII captures the overall institutional head-to-head verdict (1–3 matrix metrics and 1–1 across the 6 pillars) due to superior fundamental profitability (0.0% vs. 0.0% operating margin) and revenue trajectory (+0.0% vs. +0.0% YoY).
Technical & Structure Timing Caution: BACQ is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 10.8); meanwhile ATII trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 47.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on BACQ vs ATII. Trailing 12-month operating profitability (BACQ 0.0% vs ATII 0.0%) and valuation multiples (BACQ N/M vs ATII N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Shell Companies value chain with $212.2M market capitalization and 0.0% operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ BACQ vs ATII Key Questions & Quantitative Answers
As of Oct 21, 2026, Archimedes Tech Spac Partners Ii Co. (ATII) is the stronger overall head-to-head candidate over Bleichroeder Acquisition Corp. I Class A (BACQ) in the Tradestie Institutional Equity Comparison Engine, winning 1–3 core matrix metrics and 1–1 across our 6-pillar institutional scorecard (led by Balance Sheet & Cash Flow). BACQ carries a Unified Composite Score of 48.0/100 (HOLD) at $7.68 (N/M Forward P/E, 0.0% operating margin), whereas ATII carries 41.9/100 (SELL) at $9.81 (N/M Forward P/E, 0.0% operating margin). Composite vs. Pillar Nuance: While BACQ currently prints a higher short-term Unified Composite Score (48.0/100 HOLD vs. ATII 41.9/100 SELL), ATII captures the overall institutional head-to-head verdict (1–3 matrix metrics and 1–1 across the 6 pillars) due to superior fundamental profitability (0.0% vs. 0.0% operating margin) and revenue trajectory (+0.0% vs. +0.0% YoY). Technical & Structure Timing Caution: BACQ is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 10.8); meanwhile ATII trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 47.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
BACQ leads the Growth & Scale pillar: BACQ posts +0.0% YoY revenue growth and +0.0% YoY earnings growth on N/A TTM revenue (N/A gross margin, 0.0% operating margin), compared with ATII at +0.0% YoY revenue growth and -8.9% YoY earnings growth on N/A TTM revenue (N/A gross margin, 0.0% operating margin). On trailing 12-month operating scale, BACQ generates N/A in USD-normalized revenue versus N/A for ATII. In operating R&D and SG&A reinvestment, BACQ deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for ATII.
BACQ and ATII trade at balanced relative valuation multiples. BACQ trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas ATII trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against BACQ (0.0% ROE) versus ATII (0.0% ROE) capital efficiency.
In options market volatility and institutional positioning, BACQ carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.14β · 88% Vol realized risk). By comparison, ATII carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.19β · 150% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Oct 21, 2026. For educational research only; not investment advice.